drugset / Trial / NCT02431832

Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People

NCT02431832

Phase 1 Completed 17 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

An open-label, one-sequence, multiple administration study for exploration of microRNA and metabolomics biomarkers to predict drug induced liver injury in healthy elderly Korean people.

Timeline

Start
2015-02
Primary completion
2015-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified

Indications

No indication recorded.